Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
NeuroRx. 2005 Oct;2(4):671-82.

Translational research in central nervous system drug discovery.

Author information

  • 1Translational Research, Wyeth, Collegeville, Pennsylvania 19426, USA. hurkoo@wyeth.com

Abstract

Of all the therapeutic areas, diseases of the CNS provide the biggest challenges to translational research in this era of increased productivity and novel targets. Risk reduction by translational research incorporates the "learn" phase of the "learn and confirm" paradigm proposed over a decade ago. Like traditional drug discovery in vitro and in laboratory animals, it precedes the traditional phase 1-3 studies of drug development. The focus is on ameliorating the current failure rate in phase 2 and the delays resulting from suboptimal choices in four key areas: initial test subjects, dosing, sensitive and early detection of therapeutic effect, and recognition of differences between animal models and human disease. Implementation of new technologies is the key to success in this emerging endeavor.

PMID:
16489374
[PubMed - indexed for MEDLINE]
PMCID:
PMC1201324
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk